Global chemotherapy market is expected to witness a double digit CAGR during the forecast period owing to the rising prevalence of cancer cases and the growing requirement for its treatment. Governments in various economies are investing in healthcare sector to provide patients better healthcare facilities, which is promoting the growth of chemotherapy market. Additionally, the pharma companies are carrying out extensive research and development activities to launch novel treatment for cancer, which is expected to drive the growth of chemotherapy market in the coming years. The main objective of chemotherapy treatment is to stop or prevent the growth of cancer cells. In this treatment, chemotherapeutic agents such as anti-cancer drugs are used to stop the growth of cancer cells by killing the dividing cells. The treatment has both pros and cons. During the treatment, many healthy cells also get affected. Hence, this might limit the market growth of chemotherapy treatment.

The global chemotherapy market is segmented based on drugs, type, indication, route of administration, end-user and region. Based on route of administration, the market is segmented into intravenous, orally, transdermal, intraperitoneal, intrapleural, intrathecal, intravesical and others. Among them, the intravenous segment accounted for largest market share in 2019. However, the oral segment is expected to undergo fastest growth during the forecast period owing to its increasing demand. Oral drugs come in various forms and the patient can easily take them at home. Furthermore, the extensive research and development conducted by manufacturers to launch novel oral drugs is expected to propel its demand in the coming years.

Based on region, North America currently holds largest market share in global chemotherapy market as countries like America and Canada are hub for cancer treatments owing to their ultra-healthcare facilities and presence of world’s leading oncology drug manufacturing companies. The region is also witnessing growing prevalence of cancer, which makes it one of the largest markets for chemotherapy treatment. However, Europe is expected to undergo fastest growth during the forecast period owing to the governments’’ initiative to provide best cancer treatment.

Major players operating in the global chemotherapy market include Abbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Fresenius Kabi AG, Novartis AG, Sanofi, Merck & Co., Pfizer Inc., Roche Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Tarveda Therapeutics, Bayer AG,Johnson & Johnson Services Inc. and Celltrion Inc, among others. The companies are focusing on developing combination therapies which have the potential to reduce drug resistance. This key trend is expected to fuel the growth of global chemotherapy market in the coming years.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of global chemotherapy market from 2015 to 2018.
  • To estimate and forecast the market size of global chemotherapy market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global chemotherapy market based on drugs, type, indication, route of administration, end-user, company and regional distribution.
  • To identify dominant region or segment in the global chemotherapy market.
  • To identify drivers and challenges for global chemotherapy market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global chemotherapy market.
  • To conduct pricing analysis for global chemotherapy market.
  • To identify and analyze the profile of leading players operating in global chemotherapy market.
  • To identify key sustainable strategies adopted by market players in global chemotherapy market.


Click here to download the sample 

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of drug manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the drug manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed drug manufacturers, oncology centers and presence of all major players across the globe.

TechSci Research calculated the market size of global chemotherapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSc Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Chemotherapy drug manufacturers, hospitals/oncology centers and other stakeholders.
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to chemotherapy
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as drug manufacturers, companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global chemotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Chemotherapy Market, By Drugs:
    • Alone
    • Combination
  • Global Chemotherapy Market, By Type:
    • Alkylating Agents
    • Nitrosoureas
    • Antimetabolites
    • Anti-tumor Antibiotics
    • Topoisomerase Inhibitors
    • Mitotic Inhibitors
    • Corticosteroids
    • Others
  • Global Chemotherapy Market, By Indication:
    • Leukaemia
    • Lymphoma
    • Hodgkin Disease
    • Multiple Myeloma
    • Sarcoma
    • Bone Marrow Disease
    • Immune System Disorder
  • Global Chemotherapy Market, By Rout of Administration:
    • Intravenous
    • Orally
    • Transdermal
    • Intraperitoneal
    • Intrapleural
    • Intrathecal
    • Intravesical
    • Others
  • Global Chemotherapy Market, By End-User:
    • Intravenous Hospitals
    • Oncology centers
    • Others
  • Global Chemotherapy Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Singapore
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global chemotherapy market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Chemotherapy Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Chemotherapy Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Drugs (Alone, Combination)

6.2.2.     By Type (Alkylating Agents, Nitrosoureas, Antimetabolites, Anti-tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Others)

6.2.3.     By Indication (Leukaemia, Lymphoma, Hodgkin Disease, Multiple Myeloma, Sarcoma, Bone Marrow Disease, Immune System Disorder)

6.2.4.     By Route of Administration (Intravenous, Orally, Transdermal, Intraperitoneal, Intrapleural, Intrathecal, Intravesical, Others)

6.2.5.     By End-User (Hospitals, Oncology Centers, Others)

6.2.6.     By Company (2019)

6.2.7.     By Region

6.3.  Market Attractiveness Index

7.    Asia-Pacific Chemotherapy Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Drugs

7.2.2.     By Type

7.2.3.     By Indication

7.2.4.     By Route of Administration

7.2.5.     By End-User

7.2.6.     By Country

7.3.  Market Attractiveness Index

7.4.  Asia-Pacific: Country Analysis

7.4.1.     China Chemotherapy Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Drugs

7.4.1.2.2.             By Type

7.4.1.2.3.             By Indication

7.4.1.2.4.             By Route of Administration

7.4.1.2.5.             By End-User

7.4.2.     India Chemotherapy Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Drugs

7.4.2.2.2.             By Type

7.4.2.2.3.             By Indication

7.4.2.2.4.             By Route of Administration

7.4.2.2.5.             By End-User

7.4.3.     Japan Chemotherapy Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Drugs

7.4.3.2.2.             By Type

7.4.3.2.3.             By Indication

7.4.3.2.4.             By Route of Administration

7.4.3.2.5.             By End-User

7.4.4.     South Korea Chemotherapy Market Outlook

7.4.4.1.         Market Size & Forecast

7.4.4.1.1.             By Value

7.4.4.2.         Market Share & Forecast

7.4.4.2.1.             By Drugs

7.4.4.2.2.             By Type

7.4.4.2.3.             By Indication

7.4.4.2.4.             By Route of Administration

7.4.4.2.5.             By End-User

7.4.5.     Singapore Chemotherapy Market Outlook

7.4.5.1.         Market Size & Forecast

7.4.5.1.1.             By Value

7.4.5.2.         Market Share & Forecast

7.4.5.2.1.             By Drugs

7.4.5.2.2.             By Type

7.4.5.2.3.             By Indication

7.4.5.2.4.             By Route of Administration

7.4.5.2.5.             By End-User

7.4.6.     Australia Chemotherapy Market Outlook

7.4.6.1.         Market Size & Forecast

7.4.6.1.1.             By Value

7.4.6.2.         Market Share & Forecast

7.4.6.2.1.             By Drugs

7.4.6.2.2.             By Type

7.4.6.2.3.             By Indication

7.4.6.2.4.             By Route of Administration

7.4.6.2.5.             By End-User

8.    Europe Chemotherapy Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Drugs

8.2.2.     By Type

8.2.3.     By Indication

8.2.4.     By Route of Administration

8.2.5.     By End-User

8.2.6.     By Country

8.3.  Market Attractiveness Index

8.4.  Europe: Country Analysis

8.4.1.     France Chemotherapy Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Drugs

8.4.1.2.2.             By Type

8.4.1.2.3.             By Indication

8.4.1.2.4.             By Route of Administration

8.4.1.2.5.             By End-User

8.4.2.     Germany Chemotherapy Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Drugs

8.4.2.2.2.             By Type

8.4.2.2.3.             By Indication

8.4.2.2.4.             By Route of Administration

8.4.2.2.5.             By End-User

8.4.3.     United Kingdom Chemotherapy Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Drugs

8.4.3.2.2.             By Type

8.4.3.2.3.             By Indication

8.4.3.2.4.             By Route of Administration

8.4.3.2.5.             By End-User

8.4.4.     Italy Chemotherapy Market Outlook

8.4.4.1.         Market Size & Forecast

8.4.4.1.1.             By Value

8.4.4.2.         Market Share & Forecast

8.4.4.2.1.             By Drugs

8.4.4.2.2.             By Type

8.4.4.2.3.             By Indication

8.4.4.2.4.             By Route of Administration

8.4.4.2.5.             By End-User

8.4.5.     Russia Chemotherapy Market Outlook

8.4.5.1.         Market Size & Forecast

8.4.5.1.1.             By Value

8.4.5.2.         Market Share & Forecast

8.4.5.2.1.             By Drugs

8.4.5.2.2.             By Type

8.4.5.2.3.             By Indication

8.4.5.2.4.             By Route of Administration

8.4.5.2.5.             By End-User

8.4.6.     Spain Chemotherapy Market Outlook

8.4.6.1.         Market Size & Forecast

8.4.6.1.1.             By Value

8.4.6.2.         Market Share & Forecast

8.4.6.2.1.             By Drugs

8.4.6.2.2.             By Type

8.4.6.2.3.             By Indication

8.4.6.2.4.             By Route of Administration

8.4.6.2.5.             By End-User

9.    North America Chemotherapy Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Drugs

9.2.2.     By Type

9.2.3.     By Indication

9.2.4.     By Route of Administration

9.2.5.     By End-User

9.2.6.     By Country

9.3.  Market Attractiveness Index

9.4.  North America: Country Analysis

9.4.1.     United States Chemotherapy Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Drugs

9.4.1.2.2.             By Type

9.4.1.2.3.             By Indication

9.4.1.2.4.             By Route of Administration

9.4.1.2.5.             By End-User

9.4.2.     Mexico Chemotherapy Market Outlook

9.4.2.1.         Market Size & Forecast

9.4.2.1.1.             By Value

9.4.2.2.         Market Share & Forecast

9.4.2.2.1.             By Drugs

9.4.2.2.2.             By Type

9.4.2.2.3.             By Indication

9.4.2.2.4.             By Route of Administration

9.4.2.2.5.             By End-User

9.4.3.     Canada Chemotherapy Market Outlook

9.4.3.1.         Market Size & Forecast

9.4.3.1.1.             By Value

9.4.3.2.         Market Share & Forecast

9.4.3.2.1.             By Drugs

9.4.3.2.2.             By Type

9.4.3.2.3.             By Indication

9.4.3.2.4.             By Route of Administration

9.4.3.2.5.             By End-User

10.  South America Chemotherapy Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Drugs

10.2.2.  By Type

10.2.3.  By Indication

10.2.4.  By Route of Administration

10.2.5.  By End-User

10.2.6.  By Country

10.3.              Market Attractiveness Index

10.4.              South America: Country Analysis

10.4.1.  Brazil Chemotherapy Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Drugs

10.4.1.2.2.           By Type

10.4.1.2.3.           By Indication

10.4.1.2.4.           By Route of Administration

10.4.1.2.5.           By End-User

10.4.2.  Argentina Chemotherapy Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Drugs

10.4.2.2.2.           By Type

10.4.2.2.3.           By Indication

10.4.2.2.4.           By Route of Administration

10.4.2.2.5.           By End-User

10.4.3.  Colombia Chemotherapy Market Outlook

10.4.3.1.      Market Size & Forecast

10.4.3.1.1.           By Value

10.4.3.2.      Market Share & Forecast

10.4.3.2.1.           By Drugs

10.4.3.2.2.           By Type

10.4.3.2.3.           By Indication

10.4.3.2.4.           By Route of Administration

10.4.3.2.5.           By End-User

11.  Middle East and Africa Chemotherapy Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value & Volume

11.2.              Market Share & Forecast

11.2.1.  By Drugs

11.2.2.  By Type

11.2.3.  By Indication

11.2.4.  By Route of Administration

11.2.5.  By End-User

11.2.6.  By Country

11.3.              Market Attractiveness Index

11.4.              MEA: Country Analysis

11.4.1.  South Africa Chemotherapy Market Outlook

11.4.1.1.      Market Size & Forecast

11.4.1.1.1.           By Value

11.4.1.2.      Market Share & Forecast

11.4.1.2.1.           By Drugs

11.4.1.2.2.           By Type

11.4.1.2.3.           By Indication

11.4.1.2.4.           By Route of Administration

11.4.1.2.5.           By End-User

11.4.2.  Saudi Arabia Chemotherapy Market Outlook

11.4.2.1.      Market Size & Forecast

11.4.2.1.1.           By Value

11.4.2.2.      Market Share & Forecast

11.4.2.2.1.           By Drugs

11.4.2.2.2.           By Type

11.4.2.2.3.           By Indication

11.4.2.2.4.           By Route of Administration

11.4.2.2.5.           By End-User

11.4.3.  UAE Chemotherapy Market Outlook

11.4.3.1.      Market Size & Forecast

11.4.3.1.1.           By Value

11.4.3.2.      Market Share & Forecast

11.4.3.2.1.           By Drugs

11.4.3.2.2.           By Type

11.4.3.2.3.           By Indication

11.4.3.2.4.           By Route of Administration

11.4.3.2.5.           By End-User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled (Leading Companies)

14.2.1.  Abbott Laboratories

14.2.2.  AbbVie Inc.

14.2.3.  Amgen Inc.

14.2.4.  Astellas Pharma Inc.

14.2.5.  AstraZeneca

14.2.6.  Bristol-Myers Squibb

14.2.7.  Boehringer Ingelheim International GmbH

14.2.8.  Eli Lilly and Company

14.2.9.  Fresenius Kabi AG

14.2.10.                Novartis AG

14.2.11.                Sanofi

14.2.12.                Merck & Co.

14.2.13.                Pfizer Inc.

14.2.14.                Roche Holding AG

14.2.15.                F. Hoffmann-La Roche AG

14.2.16.                GlaxoSmithKline plc.

14.2.17.                Tarveda Therapeutics

14.2.18.                Bayer AG

14.2.19.                Johnson & Johnson Services Inc.

14.2.20.                Celltrion Inc.

15.  Strategic Recommendations

16. About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com